MiR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells

DNA Repair

Volumn 12, Issue 9, 2013, Pages 741-750

  Liu, Yixuan ^a   Xing, Rui ^a   Zhang, Xiaodong ^a   Dong, Weiwei ^b   Zhang, Jingyu ^a   Yan, Zhi ^a   Li, Wenmei ^a   Cui, Jiantao ^a   Lu, Youyong ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Etoposide; Gastric cancer; Ionizing radiation; MiR 375; P53

Indexed keywords

ETOPOSIDE; MICRORNA 375; PROTEIN P53;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IONIZING RADIATION; LOW DRUG DOSE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TREATMENT RESPONSE;

ETOPOSIDE; GASTRIC CANCER; IONIZING RADIATION; MIR-375; P53;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASE SEQUENCE; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ETOPOSIDE; GENE EXPRESSION; HCT116 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; STOMACH NEOPLASMS; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880946591     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.06.002     Document Type: Article

References (26)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., Roberts L.R., Schmittgen T.D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2008, 14:419-427.
4. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.
5. Wiemer E.A. The role of microRNAs in cancer: no small matter. Eur. J. Cancer 2007, 43:1529-1544.
6. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
7. Kuo T.Y., Hsi E., Yang I.P., Tsai P.C., Wang J.Y., Juo S.H. Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS ONE 2012, 7:e31587.
8. Zhang X., Yan Z., Zhang J., Gong L., Li W., Cui J., Liu Y., Gao Z., Li J., Shen L. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann. Oncol. 2011, 22:2257-2266.
9. Chen M.B., Wu X.Y., Yu R., Li C., Wang L.Q., Shen W., Lu P.H. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS ONE 2012, 7:e45388.
10. Muller P.A., Caswell P.T., Doyle B., Iwanicki M.P., Tan E.H., Karim S., Lukashchuk N., Gillespie D.A., Ludwig R.L., Gosselin P. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009, 139:1327-1341.
11. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
12. Zou Y., Tornos C., Qiu X., Lia M. Perez-Soler R, p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2007, 13:4900-4908.
13. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
14. Bode A.M., Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 2004, 4:793-805.
15. Smith M.L., Chen I.T., Zhan Q., O'Connor P.M., Fornace A.J. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995, 10:1053-1059.
16. Coates P.J., Save V., Ansari B., Hall P.A. Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J. Pathol. 1995, 176:19-26.
17. Adimoolam S., Ford J.M. p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair 2003, 2:947-954.
18. Scott S.L., Earle J.D., Gumerlock P.H. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation. Cancer Res. 2003, 63:7190-7196.
19. Jasty R., Lu J., Irwin T., Suchard S., Clarke M.F., Castle V.P. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells. Mol. Genet. Metabol. 1998, 65:155-164.
20. Balint E.E., Vousden K.H. Activation and activities of the p53 tumour suppressor protein. Br. J. Cancer 2001, 85:1813-1823.
21. Salem S.D., Abou-Tarboush F.M., Saeed N.M., Al-Qadasi W.D., Farah M.A., Al-Buhairi M., Al-Harbi N., Alhazza I., Alsbeih G. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines. Gene 2012, 498:300-307.
22. Kumar M., Lu Z., Takwi A.A., Chen W., Callander N.S., Ramos K.S., Young K.H., Li Y. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 2011, 30:843-853.
23. Arora H., Qureshi R., Jin S., Park A.K., Park W.Y. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp. Mol. Med. 2011, 43:298-304.
24. Girardi C., De Pitta C., Casara S., Sales G., Lanfranchi G., Celotti L., Mognato M. Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS ONE 2012, 7:e31293.
25. Hu W., Chan C.S., Wu R., Zhang C., Sun Y., Song J.S., Tang L.H., Levine A.J., Feng Z. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol. Cell 2010, 38:689-699.
26. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16:23-29.